(VIANEWS) – AMSC (AMSC.OL), ENVIPCO (ENVI.AS), VISTIN PHARMA (VISTN.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AMSC (AMSC.OL)
1395% sales growth and 8.21% return on equity
AMSC ASA, through its subsidiaries, invests in maritime assets and companies in the United States. It operates one international subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was incorporated in 2005 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, AMSC has a trailing twelve months EPS of kr-1.73.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AMSC’s EBITDA is 465.79.
More news about AMSC.
2. ENVIPCO (ENVI.AS)
94.2% sales growth and 4.02% return on equity
Envipco Holding N.V., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (RVM) for the collection and processing of used beverage containers primarily in the Netherlands, North America, and Europe. The company provides technical support, RVM maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. It also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. In addition, the company provides materials handling services primarily in the northeastern part of the United States. Envipco Holding N.V. was incorporated in 1998 and is headquartered in Amersfoort, the Netherlands.
Earnings Per Share
As for profitability, ENVIPCO has a trailing twelve months EPS of €-0.09.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.02%.
Sales Growth
ENVIPCO’s sales growth is 169.2% for the present quarter and 94.2% for the next.
Yearly Top and Bottom Value
ENVIPCO’s stock is valued at €5.95 at 12:20 EST, below its 52-week high of €6.20 and way higher than its 52-week low of €1.93.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 133.8% and 302.9%, respectively.
More news about ENVIPCO.
3. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.58. Meaning, the purchaser of the share is investing kr18.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Volume
Today’s last reported volume for VISTIN PHARMA is 2210 which is 92.44% below its average volume of 29250.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 5, 2024, the estimated forward annual dividend rate is 1.25 and the estimated forward annual dividend yield is 5.36%.
Moving Average
VISTIN PHARMA’s worth is higher than its 50-day moving average of kr23.01 and above its 200-day moving average of kr23.04.
More news about VISTIN PHARMA.
4. SPAREBANK 1 SØRØ (SOON.OL)
6.2% sales growth and 10.62% return on equity
SpareBank 1 Sørøst-Norge provides various banking products and services for private and corporate customers in Norway. The company offers mobile and online banking, card, account, and payment services. It also provides mortgage, car, boat, consumer, and other vehicle loans as well as refinancing, micro savings, investment, pension, and property related services. In addition, the company offers daily operations, get paid, loans and financing, and pension related products. Further, it provides business and personnel insurance as well as savings and investment products. The company was founded in 1859 and is headquartered in Sandefjord, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SØRØ has a trailing twelve months EPS of kr5.47.
PE Ratio
SPAREBANK 1 SØRØ has a trailing twelve months price to earnings ratio of 12.67. Meaning, the purchaser of the share is investing kr12.67 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.62%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 19, 2024, the estimated forward annual dividend rate is 3.88 and the estimated forward annual dividend yield is 5.66%.
More news about SPAREBANK 1 SØRØ.
5. VERALLIA (VRLA.PA)
6% sales growth and 46.92% return on equity
Verallia Société Anonyme manufactures and sells glass packaging products for beverages and food products worldwide. It provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.01.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing €8.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.92%.
More news about VERALLIA.
